HeartBeam, Inc. (BEAT) vs SCYNEXIS, Inc. (SCYX)

A side-by-side comparison of HeartBeam, Inc. and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BEAT

HeartBeam, Inc.

$34M

$0.61HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

SCYX

SCYNEXIS, Inc.

$31M

$4.87HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT

Total return — BEAT vs SCYX

growth of $100 · dividends reinvested · last 5y

BEAT -86.1% (-32.6%/yr)SCYX -88.9% (-35.6%/yr)BEAT compounded faster over this window

BEAT SCYX

BEAT vs SCYX: by the numbers

•BEAT is the larger company ($34M vs $31M market cap).
•Both run net losses; BEAT's is the smaller (0.00% vs -53.27% net margin).

Metrics side by side

Valuation

Metric	BEAT	SCYX
P/S ratio	N/A	1.59
P/B ratio	4.16	0.46

Profitability

Metric	BEAT	SCYX
Gross margin	0.00%	100.00%
Operating margin	0.00%	-78.03%
Net margin	0.00%	-53.27%
ROE	-248.21%	-15.29%
ROIC	-249.58%	-32.68%

Growth (annualized)

Metric	BEAT	SCYX
Revenue CAGR (5Y)	N/A	9.78%
Total return CAGR (5Y)	N/A	-34.13%

Go deeper

Full BEAT analysis Full SCYX analysis Interactive comparison tool

Dig into the metrics

HeartBeam ROE SCYNEXIS ROE HeartBeam operating margin SCYNEXIS operating margin HeartBeam revenue growth SCYNEXIS revenue growth HeartBeam free cash flow SCYNEXIS free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.